Product cited in:
Pippig, Peña-Rossi, Long et al.: "Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40)." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 163, Issue 12, pp. 6520-9, 2000 (PubMed).
Akiba, Oshima, Takeda et al.: "CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 162, Issue 12, pp. 7058-66, 1999 (PubMed).
Weinberg, Wegmann, Funatake et al.: "Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 162, Issue 3, pp. 1818-26, 1999 (PubMed).
Higgins, McDonald, Whittle et al.: "Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 162, Issue 1, pp. 486-93, 1999 (PubMed).
Weinberg, Vella, Croft: "OX-40: life beyond the effector T cell stage." in: Seminars in immunology, Vol. 10, Issue 6, pp. 471-80, 1999 (PubMed).
al-Shamkhani, Birkeland, Puklavec et al.: "OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand." in: European journal of immunology, Vol. 26, Issue 8, pp. 1695-9, 1996 (PubMed).
Baum, Gayle, Ramsdell et al.: "Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34." in: The EMBO journal, Vol. 13, Issue 17, pp. 3992-4001, 1994 (PubMed).
Stüber, Neurath, Calderhead et al.: "Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells." in: Immunity, Vol. 2, Issue 5, pp. 507-21, 1995 (PubMed).